Gain-of-function mutant p53 downregulates miR-223 contributing to chemoresistance of cultured tumor cells
出版年份 2013 全文链接
标题
Gain-of-function mutant p53 downregulates miR-223 contributing to chemoresistance of cultured tumor cells
作者
关键词
-
出版物
ONCOGENE
Volume 33, Issue 12, Pages 1601-1608
出版商
Springer Nature
发表日期
2013-04-15
DOI
10.1038/onc.2013.106
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Stathmin1 Plays Oncogenic Role and Is a Target of MicroRNA-223 in Gastric Cancer
- (2012) Wei Kang et al. PLoS One
- MicroRNA-128-2 targets the transcriptional repressor E2F5 enhancing mutant p53 gain of function
- (2011) S Donzelli et al. CELL DEATH AND DIFFERENTIATION
- In vivo Safety and Antitumor Efficacy of Bifunctional Small Hairpin RNAs Specific for the Human Stathmin 1 Oncoprotein
- (2011) Anagha P. Phadke et al. DNA AND CELL BIOLOGY
- Stathmin: a protein with many tasks. New biomarker and potential target in cancer
- (2011) Barbara Belletti et al. EXPERT OPINION ON THERAPEUTIC TARGETS
- MicroRNA-mediated breast cancer metastasis: from primary site to distant organs
- (2011) L Wang et al. ONCOGENE
- MiR-223 Suppresses Cell Proliferation by Targeting IGF-1R
- (2011) Cheng You Jia et al. PLoS One
- Stathmin, a New Target of PRL-3 Identified by Proteomic Methods, Plays a Key Role in Progression and Metastasis of Colorectal Cancer
- (2010) Ping Zheng et al. JOURNAL OF PROTEOME RESEARCH
- Targeting p53 for enhanced radio- and chemo-sensitivity
- (2009) Chao Lu et al. APOPTOSIS
- Cell-cycle regulator E2F1 and microRNA-223 comprise an autoregulatory negative feedback loop in acute myeloid leukemia
- (2009) J. A. Pulikkan et al. BLOOD
- Epithelial to Mesenchymal Transition Contributes to Drug Resistance in Pancreatic Cancer
- (2009) T. Arumugam et al. CANCER RESEARCH
- Blinded by the Light: The Growing Complexity of p53
- (2009) Karen H. Vousden et al. CELL
- Delta-Crystallin Enhancer Binding Factor 1 Controls the Epithelial to Mesenchymal Transition Phenotype and Resistance to the Epidermal Growth Factor Receptor Inhibitor Erlotinib in Human Head and Neck Squamous Cell Carcinoma Lines
- (2009) Y. Haddad et al. CLINICAL CANCER RESEARCH
- The execution of the transcriptional axis mutant p53, E2F1 and ID4 promotes tumor neo-angiogenesis
- (2009) Giulia Fontemaggi et al. NATURE STRUCTURAL & MOLECULAR BIOLOGY
- Increased MicroRNA Activity in Human Cancers
- (2009) Ariel Israel et al. PLoS One
- Integrated genomic profiling of endometrial carcinoma associates aggressive tumors with indicators of PI3 kinase activation
- (2009) H. B. Salvesen et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Expression profiling of familial breast cancers demonstrates higher expression of FGFR2 in BRCA2-associated tumors
- (2008) Anita L. Bane et al. BREAST CANCER RESEARCH AND TREATMENT
- Identification of Novel Nasopharyngeal Carcinoma Biomarkers by Laser Capture Microdissection and Proteomic Analysis
- (2008) A.-L. Cheng et al. CLINICAL CANCER RESEARCH
- Stathmin 1: a novel therapeutic target for anticancer activity
- (2008) Shushan Rana et al. Expert Review of Anticancer Therapy
- MicroRNA-223 Is Commonly Repressed in Hepatocellular Carcinoma and Potentiates Expression of Stathmin1
- (2008) Queenie W.–L. Wong et al. GASTROENTEROLOGY
- Potential role of miR-9 and miR-223 in recurrent ovarian cancer
- (2008) Alexandros Laios et al. Molecular Cancer
- Proteins induced by telomere dysfunction and DNA damage represent biomarkers of human aging and disease
- (2008) H. Jiang et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExplorePublish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn More